Meeting
2024 ASCO Annual Meeting
Neoadjuvant fractionated versus hypofractionated chemoradiotherapy in resectable and borderline resectable pancreatic cancer.
Authors
Darren Lee
University of Cincinnati Cancer Center, Cincinnati, OH
Darren Lee , Bailey Nelson , Shesh Rai , Jayesh Rai , Kyle Wang , Davendra Sohal , Olugbenga Olanrele Olowokure , Adam Rojan , Sameer H. Patel , Gregory Wilson , Syed A. Ahmad , Jordan Kharofa
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Pancreatic Cancer - Local-Regional Disease
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 4161)
DOI
10.1200/JCO.2024.42.16_suppl.4161
Abstract #
4161
Poster Bd #
141
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Clinical relevance of adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma who underwent surgery following neoadjuvant modified FOLFIRINOX.
First Author: So Heun Lee
Poster
2018 Gastrointestinal Cancers Symposium
Resection of pancreatic cancer following induction chemotherapy.
First Author: Walid Labib Shaib
Poster
2015 Gastrointestinal Cancers Symposium
Effects of neoadjuvant therapy on pancreatic cancer stem cells.
First Author: Adam R. Miller
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Analysis of survival outcomes in patients with pancreatic cancer who underwent upfront surgery.
First Author: Jae Hyup Jung